دورية أكاديمية

359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results

التفاصيل البيبلوغرافية
العنوان: 359 AMG 757, a half-life extended bispecific T-cell engager (BiTE®) immune therapy against DLL3 in SCLC: phase 1 interim results
المؤلفون: Hui Yang, Stephane Champiat, Ramaswamy Govindan, Ravi Salgia, Fiona Blackhall, Everett Vokes, Michael Boyer, Marie-Anne Damiette Smit, Melissa Johnson, Hossein Borghaei, Luis Paz-Ares Rodrigues, Rene Boosman, Horst-Dieter Hummel, W Victoria Lai, Hibiki Udagawa, Anne Chiang, Christine Hann, Mukul Minocha, Nooshin Hashemi-Sadraei, Aditya Shetty, Taofeek Owonikoko
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
بيانات النشر: BMJ Publishing Group
سنة النشر: 2020
المجموعة: Directory of Open Access Journals: DOAJ Articles
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة: article in journal/newspaper
اللغة: English
تدمد: 2051-1426
العلاقة: https://doaj.org/toc/2051-1426Test; https://doaj.org/article/f2567de972aa4a01b4c2c02dfa5cecc2Test
DOI: 10.1136/jitc-2020-SITC2020.0359
الإتاحة: https://doi.org/10.1136/jitc-2020-SITC2020.0359Test
https://doaj.org/article/f2567de972aa4a01b4c2c02dfa5cecc2Test
رقم الانضمام: edsbas.770B6C23
قاعدة البيانات: BASE
الوصف
تدمد:20511426
DOI:10.1136/jitc-2020-SITC2020.0359